180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial
Title:
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial
Author:
Munro, Alasdair P S Drysdale, Simon B Cathie, Katrina Flamein, Florence Knuf, Markus Collins, Andrea M Hill, Helen C Kaiser, Friedrich Cohen, Robert Pinquier, Didier Vassilouthis, Natalya C Carreno, Mariana Moreau, Catherine Bourron, Pierre Marcelon, Lydie Mari, Karine Roberts, Michelle Tissières, Pierre Royal, Simon Faust, Saul N
Appeared in:
The Lancet child & adolescent health
Paging:
Volume 9 () nr. 6 pages 404-412
Year:
2025
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license